When was AstraZeneca founded?

AstraZeneca was founded in 1999.

Where is AstraZeneca located?

AstraZeneca is headquartered in Cambridge, United Kingdom. It is registered at 1, Johanne Møllers Passage, København V, 1799.

How many employees does AstraZeneca have?

As of Aug 31, 2026, the latest employee count at AstraZeneca is 82020.

Is AstraZeneca a funded company?

AstraZeneca is a funded company, having raised an undisclosed amount across 29 funding rounds to date. The company's 1st funding round was a $***** PE round.

When was the latest funding round of AstraZeneca?

AstraZeneca's latest funding was a $***** Grant (prize money) round on Jul 04, 2025, with participation from 1 investor.

What is the annual revenue of AstraZeneca?

Annual revenue of AstraZeneca is between €10M and €50M as on Dec 31, 2024

Where does AstraZeneca rank among its competitors?

AstraZeneca ranks 4th amongst 1895 active competitors, of which 98 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of AstraZeneca?

AstraZeneca's top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

AstraZeneca - 2026 Company Profile, Team, Funding, Competitors & Financials

AstraZeneca is a public company based in Cambridge (United Kingdom), founded in 1999 by Amy NA. It operates as a Developer of pharmaceutical medicines for oncology and various chronic diseases. AstraZeneca has raised an undisclosed amount in funding. The company has 1895 active competitors, including 98 funded and 202 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.

Company Details

Developer of pharmaceutical medicines for oncology and various chronic diseases. Research activities focus on the discovery and production of therapeutics targeting cancer, cardiovascular conditions, renal disorders, metabolic diseases, respiratory ailments, and immunological conditions. The business also develops treatments for rare diseases and infectious conditions. Operations involve clinical trials and the application of data science to identify new molecular entities for medical use.

Website: www.astrazeneca.com
Social
Email ID: *****@astrazeneca.com
Phone Number: +44 **********
Registered Address: 1, Johanne Møllers Passage, København V, 1799

Key Metrics

Founded Year

1999

Location

Cambridge, United Kingdom

Stage

Public

Latest Funding Round

Grant (prize money), Jul 04, 2025, $*****

Investors

Digital Pharma Lab & 14 more

Ranked

4^th among 1895 active competitors

Annual Revenue

€10M - €50M as on Dec 31, 2024

Employee Count

82,020 as on Aug 31, 2026

Investment & Acquisitions

Multiply Labs & 84 more

Similar Companies

AbbVie & 1923 more

Exit Details

Public

View AstraZeneca's full profile

AstraZeneca is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
ASTRAZENECA A/S CIN: 55742928 , Denmark, Active	May 07, 1943	-	-
ASTRAZENECA D.O.O. CIN: 78608890872 , Croatia, Active	Aug 17, 2004	€10M - €50M (As on Dec 31, 2024)	-
AstraZeneca Eesti OÜ CIN: 11733875 , Estonia, Active	Oct 15, 2009	€1M - €10M (As on Dec 31, 2023)	41 (As on Jun 30, 2024)
ASTRAZENECA PHARMA INDIA LIMITED CIN: L24231KA1979PLC003563 , India, Active	Jul 11, 1979	₹1,000+ Cr (As on Mar 31, 2025)	58 (As on Oct 31, 2024)

AstraZeneca got listed on May 12, 1993.

Click here to take a look at AstraZeneca's IPO in detail

AstraZeneca has raised funding over 29 rounds. Its latest funding round was a Grant (prize money) round on Jul 04, 2025 for $*****. 1 investor participated in its latest round. AstraZeneca has 15 institutional investors.

Here is the list of recent funding rounds of AstraZeneca:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 04, 2025	5073224	Grant (prize money)	3534584	1731933	7546303	7954013
Dec 27, 2021	4630561	Post IPO	4932569	5738144	3194059	Cambridge
May 01, 2021	3929152	Grant (prize money)	6149283	4121474	9004187	Europa

Access funding benchmarks and valuations. Sign up today!

View details of AstraZeneca's funding rounds and investors

The founders of AstraZeneca is Amy NA. Pascal Soirot is the CEO of AstraZeneca.

Here are the details of AstraZeneca's key team members:

Amy NA: Founder and Chairperson, Network of Women UK of AstraZeneca.
Pascal Soirot: CEO of AstraZeneca.

View details of AstraZeneca's Founder profiles and Board Members

AstraZeneca's employee count trend

AstraZeneca has 82,020 employees as of Aug 26. Here is AstraZeneca's employee count trend over the years:

Uncover AstraZeneca's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AstraZeneca include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of AstraZeneca, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 10 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	71/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on AstraZeneca's competitors? Click here to see the top ones

AstraZeneca has made 62 investments in companies including Multiply Labs and Syneron Bio. AstraZeneca has also acquired 23 companies including Modella and EsoBiotec.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 17, 2026	Investments	Multiply Labs	2016	San Francisco (United States)
Mar 31, 2026	Investments	Syneron Bio	2022	Guangzhou (China)
Jan 13, 2026	Acquisition	Modella	2024	Boston (United States)